Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Akihiko Okayama"'
Autor:
Kazu Okuma, Madoka Kuramitsu, Toshihiro Niwa, Tomokuni Taniguchi, Yumiko Masaki, Gohzoh Ueda, Chieko Matsumoto, Rieko Sobata, Yasuko Sagara, Hitomi Nakamura, Masahiro Satake, Kiyonori Miura, Naoki Fuchi, Hideaki Masuzaki, Akihiko Okayama, Kazumi Umeki, Yoshihisa Yamano, Tomoo Sato, Masako Iwanaga, Kaoru Uchimaru, Makoto Nakashima, Atae Utsunomiya, Ryuji Kubota, Kenji Ishitsuka, Hiroo Hasegawa, Daisuke Sasaki, Ki-Ryang Koh, Mai Taki, Kisato Nosaka, Masao Ogata, Isao Naruse, Noriaki Kaneko, Sara Okajima, Kenta Tezuka, Emi Ikebe, Sahoko Matsuoka, Kazuo Itabashi, Shigeru Saito, Toshiki Watanabe, Isao Hamaguchi
Publikováno v:
Retrovirology, Vol 17, Iss 1, Pp 1-12 (2020)
Abstract Background The reliable diagnosis of human T-cell leukemia virus type 1 (HTLV-1) infection is important, particularly as it can be vertically transmitted by breast feeding mothers to their infants. However, current diagnosis in Japan require
Externí odkaz:
https://doaj.org/article/85f6e42c134e41579196a4552b884708
Autor:
Takaya Takeuchi, Yunosuke Matsuura, Yoshimasa Yamamura, Momoko Ohkusu, Shohei Koyama, Takeshi Kawaguchi, Mayumi Akaki Nagayasu, Hiroyuki Komatsu, Akihiko Okayama, Tetsunori Ishikawa, Tatsuya Atsumi, Kazuo Kitamura
Publikováno v:
Clinical Case Reports, Vol 9, Iss 9, Pp n/a-n/a (2021)
Abstract Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a “platelet dilemma” in therapeutic de
Externí odkaz:
https://doaj.org/article/9157c20decb9424381ff5bf74c808891
Autor:
Yushiro Endo, Shoichi Fukui, Tomohiro Koga, Daisuke Sasaki, Hiroo Hasegawa, Katsunori Yanagihara, Akihiko Okayama, Tatsufumi Nakamura, Atsushi Kawakami, Hideki Nakamura
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
Objective It remains unclear whether human T-cell leukemia virus type 1 (HTLV-1) infection influences therapeutic responses in patients with rheumatic diseases and whether immunosuppressive treatments increase the risk of HTLV-1-related complications
Externí odkaz:
https://doaj.org/article/2013598754ce429db214dbe93e274cf7
Autor:
Koju Kamoi, Toshiki Watanabe, Kaoru Uchimaru, Akihiko Okayama, Seiko Kato, Toyotaka Kawamata, Hisako Kurozumi-Karube, Noe Horiguchi, Yuan Zong, Yoshihisa Yamano, Isao Hamaguchi, Yasuhito Nannya, Arinobu Tojo, Kyoko Ohno-Matsui
Publikováno v:
Viruses, Vol 14, Iss 4, p 794 (2022)
HTLV-1 uveitis (HU) is the third clinical entity to be designated as an HTLV-1-associated disease. Although HU is considered to be the second-most frequent HTLV-1-associated disease in Japan, information on HU is limited compared to that on adult T-c
Externí odkaz:
https://doaj.org/article/4276c4e64a404952b8b538d0f47ae07c
Autor:
Shingo Nakahata, Chilmi Syahrul, Ayako Nakatake, Kuniyo Sakamoto, Maki Yoshihama, Ichiro Nishikata, Yoshinori Ukai, Tadashi Matsuura, Takuro Kameda, Kotaro Shide, Yoko Kubuki, Tomonori Hidaka, Akira Kitanaka, Akihiko Ito, Shigeki Takemoto, Nobuaki Nakano, Masumichi Saito, Masako Iwanaga, Yasuko Sagara, Kosuke Mochida, Masahiro Amano, Kouichi Maeda, Eisaburo Sueoka, Akihiko Okayama, Atae Utsunomiya, Kazuya Shimoda, Toshiki Watanabe, Kazuhiro Morishita
Publikováno v:
Haematologica, Vol 106, Iss 2 (2020)
Adult T-cell leukemia/leukemia (ATLL) is an aggressive peripheral T-cell malignancy, caused by infection with the human T-cell leukemia virus type 1 (HTLV-1). We have recently shown that cell adhesion molecule 1 (CADM1), a member of the immunoglobuli
Externí odkaz:
https://doaj.org/article/b03871741242448c8f07b8ce170b7626
Autor:
Kunihiko Umekita, Akihiko Okayama
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Some major research and clinical questions about human T-cell leukemia virus type 1 (HTLV-1) infection and rheumatic diseases remain: (1) Does HTLV-1 infection cause rheumatic diseases? (2) Do patients with rheumatic diseases display different respon
Externí odkaz:
https://doaj.org/article/14695ea43d6246bbbf7d702605a76146
Autor:
Kunihiko Umekita, Yayoi Hashiba, Kosho Iwao, Chihiro Iwao, Masatoshi Kimura, Yumi Kariya, Kazuyoshi Kubo, Shunichi Miyauchi, Risa Kudou, Yuki Rikitake, Katoko Takajo, Takeshi Kawaguchi, Motohiro Matsuda, Ichiro Takajo, Eisuke Inoue, Toshihiko Hidaka, Akihiko Okayama
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233159 (2020)
BACKGROUND:CD4-positive T cells are the main target of human T-cell leukemia virus type 1 (HTLV-1). Interferon-γ release assays rely on the fact that T-lymphocytes release this cytokine when exposed to tuberculosis-specific antigens and are useful i
Externí odkaz:
https://doaj.org/article/74bf7bab54da438dac439a0a32fd5216
Autor:
Kosho Iwao, Takeshi Kawaguchi, Masatoshi Kimura, Chihiro Iwao, Mao Rikitake, Ayako Aizawa, Yumi Kariya, Motohiro Matsuda, Syunichi Miyauchi, Ichiro Takajo, Takumi Kiwaki, Tsuyoshi Fukushima, Hiroaki Kataoka, Tadaki Suzuki, Akihiko Okayama, Kunihiko Umekita
Publikováno v:
Viruses, Vol 13, Iss 6, p 1086 (2021)
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tickborne infectious disease in China, Korea, and Japan caused by the SFTS virus (SFTSV). SFTS has a high mortality rate due to multiorgan failure. Recently, there are several reports
Externí odkaz:
https://doaj.org/article/35bd4f0d5c8a4f12aabaacef179e7c51
Autor:
Koju Kamoi, Akihiko Okayama, Shuji Izumo, Isao Hamaguchi, Kaoru Uchimaru, Arinobu Tojo, Kyoko Ohno-Matsui
Publikováno v:
Frontiers in Microbiology, Vol 9 (2019)
Adult T-cell leukemia/lymphoma (ATL) is a rare and aggressive T-cell malignancy with a high mortality rate, resulting in a lack of information among ophthalmologists. Here, we investigated the state of ophthalmic medical care for ATL and ATL-related
Externí odkaz:
https://doaj.org/article/674a4e8966e74a618c858956e9a7f29e
Autor:
Takeshi Kawaguchi, Kunihiko Umekita, Atsushi Yamanaka, Seiichiro Hara, Tetsuro Yamaguchi, Eisuke Inoue, Akihiko Okayama
Publikováno v:
Viruses, Vol 13, Iss 5, p 785 (2021)
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever in China, Korea, and Japan. To date, no standardized treatment protocol for SFTS has been established. Corticosteroids (CS) may be administered to patients with
Externí odkaz:
https://doaj.org/article/973f8dfc595c4047b245e540edabe7ce